The new approach, using engineered sEVs to target DR5, outperformed DR5-targeting antibodies ... vesicles to target DR5 because these nano-sized capsules—about a million times smaller than ...
Over the past 10 years, the market for monoclonal antibodies has grown exponentially. This focus issue brings together articles on the basic biology of antibodies and their therapeutic use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback